327 related articles for article (PubMed ID: 26658617)
1. Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.
Gao R; Cheng J; Fan C; Shi X; Cao Y; Sun B; Ding H; Hu C; Dong F; Yan X
Sci Rep; 2015 Dec; 5():18175. PubMed ID: 26658617
[TBL] [Abstract][Full Text] [Related]
2. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
3. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
4. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
5. Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.
Zhang S; Tuo P; Ji Y; Huang Z; Xiong Z; Li H; Ruan C
J Cancer Res Clin Oncol; 2024 Jun; 150(6):310. PubMed ID: 38890166
[TBL] [Abstract][Full Text] [Related]
6. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
7. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus.
Cong M; Ou X; Huang J; Long J; Li T; Liu X; Wang Y; Wu X; Zhou J; Sun Y; Shang Q; Chen G; Ma H; Xie W; Piao H; Yang Y; Gao Z; Xu X; Tan Z; Chen C; Zeng N; Wu S; Kong Y; Liu T; Wang P; You H; Jia J; Zhuang H
OMICS; 2020 Jul; 24(7):415-423. PubMed ID: 32522092
[TBL] [Abstract][Full Text] [Related]
8. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
10. A New Strategy for Analyzing Time-Series Data Using Dynamic Networks: Identifying Prospective Biomarkers of Hepatocellular Carcinoma.
Huang X; Zeng J; Zhou L; Hu C; Yin P; Lin X
Sci Rep; 2016 Aug; 6():32448. PubMed ID: 27578360
[TBL] [Abstract][Full Text] [Related]
11. Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.
Baniasadi H; Gowda GA; Gu H; Zeng A; Zhuang S; Skill N; Maluccio M; Raftery D
Electrophoresis; 2013 Oct; 34(19):2910-7. PubMed ID: 23856972
[TBL] [Abstract][Full Text] [Related]
12. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells.
Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL
Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150
[TBL] [Abstract][Full Text] [Related]
13. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
14. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma.
Cai FF; Song YN; Lu YY; Zhang Y; Hu YY; Su SB
Aging (Albany NY); 2020 Jul; 12(14):14949-14965. PubMed ID: 32701483
[TBL] [Abstract][Full Text] [Related]
15. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
[TBL] [Abstract][Full Text] [Related]
16. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
Huang BY; Tsai MR; Hsu JK; Lin CY; Lin CL; Hu JT; Huang YW; Liu CJ; Wu WJ; Wu CF; Sung FY; Chen PJ; Liang HJ; Lin SM; Yu MW
Mol Carcinog; 2020 Nov; 59(11):1269-1279. PubMed ID: 32914490
[TBL] [Abstract][Full Text] [Related]
18. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
[TBL] [Abstract][Full Text] [Related]
19. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.
Zhou L; Ding L; Yin P; Lu X; Wang X; Niu J; Gao P; Xu G
J Proteome Res; 2012 Nov; 11(11):5433-42. PubMed ID: 22946841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
